Nothing Special   »   [go: up one dir, main page]

CY1119317T1 - Συνθεση για τοπικη εφαρμογη, χρησεις αυτης, συσκευη εφαρμογης και kit μερων - Google Patents

Συνθεση για τοπικη εφαρμογη, χρησεις αυτης, συσκευη εφαρμογης και kit μερων

Info

Publication number
CY1119317T1
CY1119317T1 CY20171100685T CY171100685T CY1119317T1 CY 1119317 T1 CY1119317 T1 CY 1119317T1 CY 20171100685 T CY20171100685 T CY 20171100685T CY 171100685 T CY171100685 T CY 171100685T CY 1119317 T1 CY1119317 T1 CY 1119317T1
Authority
CY
Cyprus
Prior art keywords
composition
appliances
local application
skin
part kits
Prior art date
Application number
CY20171100685T
Other languages
English (en)
Inventor
Robert Sebastian Stal
Original Assignee
Youmedical B.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Youmedical B.V. filed Critical Youmedical B.V.
Publication of CY1119317T1 publication Critical patent/CY1119317T1/el

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q3/00Manicure or pedicure preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12Carboxylic acids; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36Carboxylic acids; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36Carboxylic acids; Salts or anhydrides thereof
    • A61K8/365Hydroxycarboxylic acids; Ketocarboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/005Antimicrobial preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/87Application Devices; Containers; Packaging
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M35/00Devices for applying media, e.g. remedies, on the human body

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • Birds (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Η εφεύρεση σχετίζεται με μία σύνθεση για τοπική εφαρμογή, που περιλαμβάνει τουλάχιστον ένα φυσιολογικά αποδεκτό οξύ κατάλληλο για την μείωση του pΗ του δέρματος ενός ατόμου που υποβάλλεται σε θεραπεία μέχρι μιας περιοχή μεταβολής 1,5-4,5, και ένα φυσιολογικά αποδεκτό φορέα. Η εφεύρεση σχετίζεται περαιτέρω με διάφορες χρήσεις για την θεραπεία παθήσεων του δέρματος και των νυχιών, που περιλαμβάνουν ειδική εστίαση σε μικροβιολογικές μολύνσεις του δέρματος (ονυχομύκωση (onychomycosis)). Η εφεύρεση σχετίζεται περαιτέρω με μία συσκευή εφαρμογής και κιτ μερών που περιλαμβάνουν αυτή την σύνθεση.
CY20171100685T 2009-11-11 2017-06-28 Συνθεση για τοπικη εφαρμογη, χρησεις αυτης, συσκευη εφαρμογης και kit μερων CY1119317T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NL2003786A NL2003786C2 (en) 2009-11-11 2009-11-11 COMPOSITION FOR TOPICAL APPLICATION, USES THEREOF, APPLICATOR DEVICE AND KIT OF PARTS.
PCT/NL2010/050750 WO2011059324A2 (en) 2009-11-11 2010-11-11 Composition for topical application, uses thereof, applicator device and kit of parts

Publications (1)

Publication Number Publication Date
CY1119317T1 true CY1119317T1 (el) 2018-02-14

Family

ID=41728553

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20171100685T CY1119317T1 (el) 2009-11-11 2017-06-28 Συνθεση για τοπικη εφαρμογη, χρησεις αυτης, συσκευη εφαρμογης και kit μερων

Country Status (15)

Country Link
US (1) US20120269751A1 (el)
EP (2) EP2498752B1 (el)
CY (1) CY1119317T1 (el)
DK (2) DK3269358T3 (el)
ES (2) ES2631953T3 (el)
HR (1) HRP20171003T1 (el)
HU (1) HUE035285T2 (el)
LT (1) LT2498752T (el)
NL (1) NL2003786C2 (el)
PL (1) PL2498752T3 (el)
PT (1) PT2498752T (el)
RS (1) RS56185B1 (el)
SI (1) SI2498752T1 (el)
SM (1) SMT201700327T1 (el)
WO (1) WO2011059324A2 (el)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9301935B2 (en) 2013-06-10 2016-04-05 Naeem Uddin Broad spectrum pharmacological composition for treatment of various infections and diseases and methods of use
US10493050B2 (en) 2013-06-10 2019-12-03 Naeem Uddin Broad spectrum pharmacological composition for treatmentof various infections and diseases and methodsof use
US11110072B2 (en) 2013-06-10 2021-09-07 Greyfer Innova Pharma, Llc Broad spectrum pharmacological composition for treatment of various infections and diseases and methods of use
US10646461B2 (en) 2013-06-10 2020-05-12 Naeem Uddin Broad spectrum pharmacological composition for treatment of various infections and diseases and methods of use
BE1025004B1 (nl) * 2017-02-24 2018-09-24 Oystershell Nv Afpelbare nagellak
BR112020008282A2 (pt) * 2017-10-30 2020-10-20 Kaken Pharmaceutical Co., Ltd. preparação externa para tratar trichophytosis unguium
EP3802524A1 (en) 2018-05-29 2021-04-14 Cersci Therapeutics, Inc. Compounds for pain treatment, compositions comprising same, and methods of using same
US20210212930A1 (en) * 2018-05-30 2021-07-15 Eviderm Institute Ab Mild composition for use in topical treatment of skin and nail disorders caused by virus and fungus
MX2020013916A (es) * 2018-06-19 2021-05-27 Rosesta Medical B V Dispositivo de asistencia para concepcion intravaginal, kit de piezas, y metodo para aumentar probabilidades de embarazo.
US20200246316A1 (en) * 2019-02-01 2020-08-06 Cersci Therapeutics, Inc. Methods of treating post-surgical pain with a thiazoline anti-hyperalgesic agent
AU2020275683A1 (en) 2019-05-10 2021-11-04 Cersci Therapeutics, Inc. Manufacturing methods and polymorphs of a thiazoline anti-hyperalgesic agent
BE1028165B1 (nl) 2020-03-26 2021-10-25 Oystershell Nv Samenstelling voor de behandeling van nagelschimmel

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2394290A1 (fr) * 1977-06-13 1979-01-12 Unilever Nv Composition desodorisante pour application topique sur la peau
SE462139B (sv) * 1986-02-04 1990-05-14 Sven Moberg Farmaceutisk komposition, innehaallande propylenglykol och karbamid, foer behandling av bl.a. nagelsvamp och seborroiskt eksem
WO1992013529A1 (en) * 1991-02-01 1992-08-20 Stiefel Laboratories, Inc. Improved flexible collodion compositions
FR2673537B1 (fr) 1991-03-08 1993-06-11 Oreal Utilisation d'agents de penetration hydrophiles dans les compositions dermatologiques pour le traitement des onychomycoses, et compositions correspondantes.
JPH0739325B2 (ja) * 1991-06-24 1995-05-01 株式会社島津製作所 住居用防カビ剤
DE59911740D1 (de) 1998-09-10 2005-04-14 Bioequal Ag Muttenz Topisch anwendbare mittel gegen nagelpilzerkrankungen
US6664292B2 (en) * 2001-06-04 2003-12-16 Mark H. Bogart Methods for the treatment of nail fungus and other microbial and mycotic conditions and compositions useful therefor
ES2301814T3 (es) * 2002-09-05 2008-07-01 Galderma S.A. Solucion para aplicacion ungueal.
US7135194B2 (en) 2002-09-27 2006-11-14 Birnbaum Jay E Subunguicide, and method for treating onychomycosis
US20050020678A1 (en) 2003-07-23 2005-01-27 Denton Robert Michael Environmentally safe fungicides
FR2867978B1 (fr) * 2004-03-29 2009-02-20 Galderma Res & Dev Patch d'amorolfine pour le traitement de l'onychomicose
US20060110415A1 (en) * 2004-11-22 2006-05-25 Bioderm Research Topical Delivery System for Cosmetic and Pharmaceutical Agents
EP1819225A2 (en) * 2004-12-09 2007-08-22 The Dial Corporation Compositions having a high antiviral and antibacterial efficacy
WO2007070795A2 (en) * 2005-12-12 2007-06-21 The Trustees Of Columbia University In The City Of New York Broad spectrum non-traditional preservative system
JP5184341B2 (ja) * 2006-03-08 2013-04-17 日本農薬株式会社 外用の医薬組成物
US20080112908A1 (en) * 2006-11-15 2008-05-15 Srulevitch David B Anti-fungal nail lacquer
US8790671B2 (en) * 2007-04-20 2014-07-29 Bioequal Ag Topical fungicidal agents for treating nail disorders

Also Published As

Publication number Publication date
EP2498752B1 (en) 2017-04-12
NL2003786A1 (nl) 2010-01-11
DK3269358T3 (da) 2020-11-02
NL2003786C2 (en) 2010-07-30
RS56185B1 (sr) 2017-11-30
EP3269358B1 (en) 2020-08-05
WO2011059324A3 (en) 2012-01-05
ES2829273T3 (es) 2021-05-31
HRP20171003T1 (hr) 2017-09-22
HUE035285T2 (en) 2018-05-02
ES2631953T3 (es) 2017-09-06
WO2011059324A4 (en) 2012-03-01
LT2498752T (lt) 2017-07-25
PT2498752T (pt) 2017-07-12
SMT201700327T1 (it) 2017-09-07
DK2498752T3 (en) 2017-07-24
SI2498752T1 (sl) 2017-10-30
WO2011059324A2 (en) 2011-05-19
EP2498752A2 (en) 2012-09-19
EP3269358A1 (en) 2018-01-17
PL2498752T3 (pl) 2017-09-29
US20120269751A1 (en) 2012-10-25

Similar Documents

Publication Publication Date Title
CY1119317T1 (el) Συνθεση για τοπικη εφαρμογη, χρησεις αυτης, συσκευη εφαρμογης και kit μερων
CY1123052T1 (el) Συνθεσεις και μεθοδοι σχετικες με παραλλαγες της πρωτεϊνες α (spa)
CY1121135T1 (el) Ενωσεις υποκατεστημενης τετρακυκλιnhς για την θεραπευτικη αγωγη φλεγμονωδων διαταραχων του δερματος
CY1123625T1 (el) Συνθεσεις και μεθοδοι για θεραπεια διαταραχων χρησης αλκοολης, πονου και αλλων ασθενειων
CY1119030T1 (el) Χρηση των δεσμων σιγμα στον πονο του καρκινου των οστων
EA201170521A1 (ru) Новые соединения
MX2010005244A (es) Composiciones y métodos para la terapia y el diagnóstico de influenza.
EA200802213A1 (ru) Способы лечения заболеваний крови
EA201100335A1 (ru) Производные пурина для применения при лечении связанных с fab заболеваний
ATE489957T1 (de) Mittel zur behandlung von entzündlichen erkrankungen
BRPI0921999B8 (pt) uso de uma quantidade terapeuticamente eficaz de células tronco placentárias
BRPI0514017A (pt) indazóis úteis no tratamento de doenças cardiovasculares
EA201100505A1 (ru) Органические соединения для применения для лечения бактериальных инфекций
TR200906131T1 (tr) Aktivin -actrIIa antagonistleri ve göğüs kanserinin tedavi e
BRPI0512856A (pt) métodos e reagentes para o tratamento de distúrbios metabólicos
CY1111579T1 (el) Νεα συνδυασμενη χρηση μιας ενωσης σουλφοναμιδης (sulfonamide) στην θεραπεια του καρκινου
BRPI0418251A (pt) fosfonatos, monofosfonamidatos, bisfosfonamidatos para o tratamento de doenças virais
EA201100564A1 (ru) Антипролиферативные соединения
NO20091661L (no) Anvendelse av pegylert IL-10 for a behandle kreft
BR112012014715A2 (pt) "processo de tratamento cosmético da pele, e, conjunto cosmético"
TR201900542T4 (tr) Ağrı ve/veya enflamasyon tedavisi için bileşimler.
CY1117562T1 (el) Τριαζολοπυριδινες ως αναστολεις φωσφοδιεστερασης για την θεραπεια δερματικων ασθενειων
CL2007002384A1 (es) Uso de compuestos derivados de 2,5-dihidroxibenceno para el tratamiento de la psoriasis.
EA200701995A1 (ru) Способы уменьшения кальцификации
CY1115690T1 (el) Συνθεσεις βασιζομενες σε arthrospirα και χρησεις αυτων